Introduction

Excipient hypersensitivity reactions often remain unrecognized in clinical practice, posing significant risks of repeated anaphylaxis. While clinicians typically focus on active pharmaceutical ingredients, the European Academy of Allergy and Clinical Immunology (EAACI) emphasizes that additives like stabilizers and preservatives can trigger severe responses. Because these compounds exist across various drug classes, a patient might react to seemingly unrelated medications. Therefore, identifying the specific culprit is essential for long-term patient safety.

Identifying Excipient Hypersensitivity Reactions in Patients

Clinicians should maintain a high index of suspicion when patients report a history of anaphylaxis to multiple, chemically unrelated drugs. For instance, specific formulations like injectable depot steroids, oral laxatives, and certain progestogens frequently contain high-risk excipients. Common offenders include polyethylene glycol (PEG), gelatine, povidone, mannitol, and various methylcelluloses. Consequently, reviewing the product monograph becomes a critical diagnostic step for any unexplained drug reaction.

Diagnostic Recommendations and Clinical Management

According to the EAACI position paper, the evaluation must involve a thorough review of the pharmaceutical formulation. If an excipient is suspected, specific diagnostic tests should be performed. These include skin prick tests, intradermal testing, and in vitro assays. In some cases, provocation testing with pure excipients may be necessary. Furthermore, using drugs with and without the suspected excipient serves as a vital control during the diagnostic process. Once confirmed, management requires strict avoidance of all products containing the identified culprit.

Frequently Asked Questions

When should I suspect an excipient allergy instead of an active ingredient allergy?

You should suspect an excipient allergy if the patient reacts to multiple drugs with unrelated active ingredients or to specific classes like oral laxatives and depot injections.

What are the most common excipients responsible for these reactions?

The most common culprits identified by the EAACI include polyethylene glycol (PEG), methylcelluloses, gelatine, povidone, and mannitol.

How should a clinician start the diagnostic workup?

Start by reviewing the product monograph for all suspected drugs. Then, proceed with skin, in vitro, or provocation testing using the pure excipient when appropriate.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Garvey LH et al. Hypersensitivity to Excipients in Drugs: An EAACI Position Paper. Allergy. 2026 Apr 08. doi: 10.1111/all.70324. PMID: 41952048.


2. Caballero ML, Quirce S. Excipients as potential agents of anaphylaxis. Frontiers in Pharmacology. 2020. doi: 10.3389/fphar.2020.01157.


3. Stone CA, et al. Immediate-type hypersensitivity to polyethylene glycols: A review. Journal of Allergy and Clinical Immunology: In Practice. 2019. doi: 10.1016/j.jaip.2018.12.003.